At close: December 16 at 4:00:01 PM EST
After hours: 7:59:55 PM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-46,265.2230
-32,376.9740
-25,222.3010
-22,568.8380
-13,932.7430
Investing Cash Flow
-309.6650
-864.0380
-225.9710
-141.3610
-62.3530
Financing Cash Flow
61,851.8160
22,939.6420
9,610.6550
1,248.7970
60,545.7510
End Cash Position
34,263.3710
9,564.9880
19,866.3580
35,703.9750
57,165.3770
Interest Paid Supplemental Data
--
--
--
--
1.5840
Capital Expenditure
-309.6650
-864.0380
-225.9710
-141.3610
-62.3530
Issuance of Capital Stock
--
22,150.0000
9,610.6550
34.8730
59,719.2560
Issuance of Debt
--
--
--
--
184.0000
Free Cash Flow
-46,574.8880
-33,241.0120
-25,448.2720
-22,710.1990
-13,995.0960
12/31/2020 - 11/10/2005
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
QTTB Q32 Bio Inc.
3.5000
-5.41%
CRVO CervoMed Inc.
1.9500
+2.63%
KROS Keros Therapeutics, Inc.
19.42
+3.13%
RPTX Repare Therapeutics Inc.
1.6000
-9.60%
BIOR Biora Therapeutics, Inc.
0.5941
+8.02%
ASMB Assembly Biosciences, Inc.
15.54
+1.90%
SPRB Spruce Biosciences, Inc.
0.3887
+1.44%
TFFP TFF Pharmaceuticals, Inc.
0.0650
-60.05%
ANAB AnaptysBio, Inc.
16.65
+6.80%
AFMD Affimed N.V.
2.1300
-0.93%